Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.52 HKD
56.74 M HKD
4.86 B HKD
25.92 M
About CHARMACY PHARMACEUTICAL CO LTD
Sector
CEO
Chuang Long Yao
Headquarters
Shantou
Website
Founded
1984
ISIN
CNE1000023D6
FIGI
BBG00BL4M0D4
Charmacy Pharmaceutical Co., Ltd. engages in the pharmaceutical distribution business. It mainly distributes western medicine, Chinese patent medicine and healthcare products to downstream distributors and retail terminals. The company was founded on February 18, 1984, and is headquartered in Shantou, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 2289 is 9.26 HKD — it has decreased by −2.53% in the past 24 hours. Watch CHARMACY PHARMACEUTICAL CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange CHARMACY PHARMACEUTICAL CO LTD stocks are traded under the ticker 2289.
2289 stock has fallen by −0.43% compared to the previous week, the month change is a 11.84% rise, over the last year CHARMACY PHARMACEUTICAL CO LTD has showed a −19.48% decrease.
2289 reached its all-time high on Aug 29, 2023 with the price of 20.00 HKD, and its all-time low was 4.01 HKD and was reached on Mar 25, 2021. View more price dynamics on 2289 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
2289 stock is 2.59% volatile and has beta coefficient of 0.81. Track CHARMACY PHARMACEUTICAL CO LTD stock price on the chart and check out the list of the most volatile stocks — is CHARMACY PHARMACEUTICAL CO LTD there?
Today CHARMACY PHARMACEUTICAL CO LTD has the market capitalization of 1.03 B, it has increased by 2.15% over the last week.
Yes, you can track CHARMACY PHARMACEUTICAL CO LTD financials in yearly and quarterly reports right on TradingView.
CHARMACY PHARMACEUTICAL CO LTD is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
2289 net income for the last half-year is 28.98 M HKD, while the previous report showed 27.00 M HKD of net income which accounts for 7.35% change. Track more CHARMACY PHARMACEUTICAL CO LTD financial stats to get the full picture.
CHARMACY PHARMACEUTICAL CO LTD dividend yield was 2.54% in 2023, and payout ratio reached 62.78%. The year before the numbers were 7.24% and 51.21% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 22, 2024, the company has 831.00 employees. See our rating of the largest employees — is CHARMACY PHARMACEUTICAL CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHARMACY PHARMACEUTICAL CO LTD EBITDA is 175.91 M HKD, and current EBITDA margin is 3.14%. See more stats in CHARMACY PHARMACEUTICAL CO LTD financial statements.
Like other stocks, 2289 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHARMACY PHARMACEUTICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHARMACY PHARMACEUTICAL CO LTD technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHARMACY PHARMACEUTICAL CO LTD stock shows the neutral signal. See more of CHARMACY PHARMACEUTICAL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.